Renerve Limited · ASX:RNV
Renerve — Q4 FY26 Earnings Presentation
22 slides from Renerve's earnings presentation, Aug 19, 2026
Slide 1: Transforming Nerve Repair Through Science
For personal use only ASX:RNV Transforming Nerve Repair Through Science ReNerve Company presentation | Quarterly webinar | August 2026
Slide 2: Important Notice & Disclaimer
Important Notice & Disclaimer Nature of Document: This presentation has been prepared and issued by ReNerve Ltd Disclaimer: No representation or warranty, express or implied, is made by the Company that (Company) to provide general information about the Company. The information in this the material
Slide 3: Executive Summary
Executive Summary Summary For personal use only Development of Novel Expanding Strong Sales & Nerve Repair & Product Portfolio Distribution Presence Regeneration Products ReNerve is developing a comprehensive 3 product ranges in the US market ReNerve has established logistics, portfolio of products
Slide 4: Quarter Highlights
Executive Quarter Summary highlights For personal use only Revenue up >50% Compared to the previous qtr Annual revenue up 88% Cash of $1.48M Signed a $5M funding facility with Riverfort in early July ReNerve Company presentation | August 2026 4
Slide 5: Financial Snapshot Q4 FY26
Financials Financial Snapshot Q4 FY26 For personal use only Cash Position Stock A$0.08 A$1.48M Price per share Q4 FY26 Revenue Capital Raised (July 2026) A$211K 80% increase vs A$5M funding facility corresponding Q4 FY25 Riverfort facility against the R&D tax quarter in FY25 rebates 5 ReNerve Compan
Slide 6: Distribution milestones across the NervAlign range
Executive Quarter Summary highlights For personal use only Distribution milestones across the NervAlign® range • Distribution partners in Hong Kong and Malaysia • Nerve Guide Matrix enters Stage 3 of 4 Stage process to FDA submission • Post quarter end – additional regional approvals in India, the P
Slide 7: Company Portfolio
Company Portfolio Product Product Commercial On Market R&D Development Development For personal use only Nerve Cuff Nerve Tube Nerve Protector Nerve Guide Matrix Nerve Cap Dermal Tissue AmnioLite AmnioDuo Placental ReNerve Company presentation | August 2026 7
Slide 8: Global Nerve Repair Biomaterials Market
Target 2031 Market USD$6.0Bn USD$6.19Bn For personal use only The Global Nerve Repair Biomaterials Market is projected to grow at a compound annual growth rate (CAGR) of 17.8% from 2024 to 2031 to USD$6.19Bn. Our Target Markets Global Nerve Repair Biomaterial Market Dermal and Amniotic Tissue 2025 S
Slide 9: Sales and Marketing Update
Sales and Marketing US Market Expanded Update Distribution Channels Robust Portfolio For personal use only • Expanded to 21 distributors across the US • Full logistics, warehousing and invoicing in place • Distributors can sell the entire ReNerve product range • Will add additional distributors to t
Slide 10: Asia Expansion
Asia Hong Kong India For personal use only • Strong local partner • Significant opportunity • Existing distribution partner in • Had initial orders and sales place last quarter • Surgeon and hospital • Now engaging with the engagement already local market underway Philippines Malaysia • Complements
Slide 11: Nerve Cuff
For personal use only Wound Care Overview and Information Nerve Cuff RN-SM-TRN-012 Rev.0
Slide 12: Key Features: ReNerve's Align Product
Key Features ReNerve’s “Align” 1 Product Clinical Study For personal use only • Protects nerves during recovery post peripheral nerve repair • Great handling characteristics and absorbed within 6 Patient Results months 2 Definitive clinical study on using NervAlign Nerve Patient Benefit Cuff for ner
Slide 13: The Align Study
The “Align” Study Clinical Study on the NervAlign® Nerve Cuff Undertaking a definitive study in nerve repair following surgical neurolysis to show the benefit of protecting the nerve post nerve Comparison of Patient Pre & Post For personal use only repair surgery. Surgery Pain Score 7.1 7.1 Study De
Slide 14: Product Development Pipeline
For personal use only Wound Care Overview and Information Product Development Pipeline RN-SM-TRN-012 Rev.0
Slide 15: Product Development Pipeline
Product Development Pipeline For personal use only Nerve Conduit and protector ranges Nerve ● Entering validation commercial production conduit range this quarter ● 3 types of conduits to come to market In commercial development Stage 3 of 4 Nerve FDA approval pathway confirmed guide matrix 12-month
Slide 16: Product Range
For personal use only Wound Care Overview and Information Product Range RN-SM-TRN-012 Rev.0
Slide 17: Empliq Product Portfolio
Empliq Product Portfolio For personal use only Empliq AmnioLite Empliq AmnioDuo Empliq Placental Empliq Dermal Description Single-layer amniotic membrane Double-layer amniotic membrane Placental allograft including amniotic Deep-layer dermal matrix allograft allograft membrane and chorion Clinical V
Slide 18: Catalysts CY26
Executive Catalysts Summary CY26 For personal use only Continued focus on sales expansion as first direct sales reps starting to impact revenue growth NervAlign® Nerve Cuff launches and sales across India and Asia Complete recruitment of the “Align” study in peripheral nerve repairs European approva
Slide 19: Value drivers for the next 12 months
Empliq products ranges Continue to expand into Value drivers for now in the US market Ex-US markets For personal use only the next 12 months ● Complements the nerve products sales ● ● Establishing partners Ex-USA Initial product launches across ● Anticipating faster sales growth India and Asia throu
Slide 20: Investment Highlights
Investment Highlights For personal use only In Market Products Immediate Market Need Growing Market Nerve Cuff transitioned from R&D to Products promote nerve injury recovery and Nerve repair biomaterials & related markets are commercial sales with 3 product lines in wound repair leading to faster p
Slide 21: Contact Us
Contact Us For personal use only ReNerve Limited +61 (03) 9482 3940 info@renerve.com.au Level 10/99 Queen St, Melbourne, Victoria 3000 Australia Follow us on socials!
Slide 22: ReNerve's Nerve Opportunity
ReNerve’s Nerve Opportunity Nerve Cuff Nerve Conduit Nerve Guide Matrix Bionic Nerve For personal use only • Used on damaged or transected • Improved Nerve Cuff developed from • An ‘off-the-shelf’, ready to use nerve • An ‘off-the-shelf’, continuous nerve Product nerves with no gaps or gap closure s